People who carry the APOE4 genetic variant face a substantial risk for developing Alzheimer’s disease. Now, researchers have identified a compound that targets the APOE protein in the brains of mice and protects against damage induced by the Alzheimer’s protein amyloid beta. The findings indicate that APOE could potentially be a real target for treatment or prevention.